3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Neoplasms
4
Breast Neoplasms
4
Myeloproliferative Disorders
3
Melanoma
3
Skin Neoplasms
2
Lung Neoplasms
2
Thrombosis
1
Pyruvate Kinase Deficiency of Red Cells
1
Precancerous Conditions
1
Pancreatic Cyst
1
Neuroendocrine Tumors
1
Neoplasm, Residual
1
Myelodysplastic-Myeloproliferative Diseases
1
Myelodysplastic Syndromes
1
Myelitis, Transverse
1
Myasthenia Gravis
1
Multiple Sclerosis
1
Metastatic Castration-resistant Prostate Cancer
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma, B-Cell
1
Lymphatic Metastasis
1
Locally Advanced Head and Neck Carcinoma
1
Leukemia, Myeloid, Acute
1
Head and Neck Neoplasms
1
HER2-positive Breast Cancer
1
Esophageal Neoplasms
1
Endometrial Neoplasms
1
Diagnosis of Cancer of Various Organs
1
Diabetes Mellitus, Insulin-Dependent, 12
1
Interventions
Cisplatin
5
Gemcitabine
4
Oxaliplatin
2
Irinotecan
2
Fluorouracil
2
Capecitabine
2
Bevacizumab
2
zanidatamab
1
toripalimab
1
pembrolizumab
1
niraparib
1
neratinib
1
ivosidenib
1
futibatinib
1
fludarabine
1
envafolimab
1
encorafenib
1
durvalumab
1
binimetinib
1
Trastuzumab
1
Pemetrexed
1
Nivolumab
1
Folfox protocol
1
Docetaxel
1
Cyclophosphamide
1
Cetuximab
1
Carboplatin
1
Actigraphy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Biliary Tract Neoplasms
×
Blood Specimen Collection
×
30 days
×
Clear all
No trials found.